IGFBP1 and metabolic dysfunction-associated steatohepatitis: In conclusion, our data have demonstrated that hepatic WTAP is a key integrative regulator of ectopic lipid accumulation and inflammation during NASH progression with an involvement of IGFBP1, CD36 and cytochemokines such as CCL2.